Citations (64)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ahmed Sayed, Malak Munir, Noor Eweis, Doaa Wael, Omar Shazly, Ahmed K. Awad, Marihan A. Elbadawy & Sanaa Eissa. (2020) An overview on precision therapy in bladder cancer. Expert Review of Precision Medicine and Drug Development 5:5, pages 347-361.
Read now
Read now
Adam R Metwalli & Ashish M Kamat. (2006) Controversial issues and optimal management of stage T1G3 bladder cancer. Expert Review of Anticancer Therapy 6:8, pages 1283-1294.
Read now
Read now
Articles from other publishers (62)
Shoshana J. Rosenzweig, Daniel Ranti, Reza Mehrazin, John P. Sfakianos, Peter N. Wiklund & Nikhil Waingankar. (2023) Characteristics Contributing to Survival Differences Between Black and White Patients Following Cystectomy. Urologic Oncology: Seminars and Original Investigations 41:4, pages 207.e1-207.e7.
Crossref
Crossref
Shuaishuai Li, Rui Chen, Ashok Raj, Ning Xue, Fangzheng Zhao, Xihao Shen, Yunpeng Peng & Haitao Zhu. (2022) Impact of the time of surgical delay on survival in patients with muscle-invasive bladder cancer. Frontiers in Oncology 12.
Crossref
Crossref
Jeffrey J. Leow, Wei Shen Tan, Wei Phin Tan, Teck Wei Tan, Vinson Wai-Shun Chan, Kari A. O. Tikkinen, Ashish Kamat, Shomik Sengupta, Maxwell V. Meng, Shahrokh Shariat, Morgan Roupret, Karel Decaestecker, Nikhil Vasdev, Yew Lam Chong, Dmitry Enikeev, Gianluca Giannarini, Vincenzo Ficarra & Jeremy Yuen-Chun Teoh. (2022) A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyond. Frontiers in Surgery 9.
Crossref
Crossref
Mario Pones, David D’Andrea, Keiichiro Mori, Mohammad Abufraj, Marco Moschini, Eva Comperat & Shahrokh F. Shariat. (2021) Differential Prognosis and Response of Denovo vs. Secondary Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis. Cancers 13:10, pages 2496.
Crossref
Crossref
Neel H. PatelGus MirandaJie CaiMihir DesaiInderbill GillMonish Aron. (2021) Robotic Radical Cystectomy Outcomes after Intervention for Prostate Cancer. Journal of Endourology 35:5, pages 633-638.
Crossref
Crossref
Benjamin W. Fischer-Valuck, Jeff M. Michalski, Joanna G. Harton, Alison Birtle, John P. Christodouleas, Jason A. Efstathiou, Vivek K. Arora, Eric H. Kim, Eric M. Knoche, Russell K. Pachynski, Joel Picus, Yuan James Rao, Melissa Reimers, Bruce J. Roth, Paul Sargos, Zachary L. Smith, Mohamed S. Zaghloul, Hiram A. Gay, Sagar A. Patel & Brian C. Baumann. (2021) Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent Chemoradiotherapy. Clinical Genitourinary Cancer 19:1, pages 41-46.e1.
Crossref
Crossref
Ahmad M. El-Arabi, Syed M. Alam, Garth Sherman, William P. Parker, Jeffrey Thompson, Jeffrey M. Holzbeierlein, Eugene K. Lee & Elizabeth M. Wulff-Burchfield. (2020) Etiology of Treatment Delays in Patients Receiving Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer. Bladder Cancer 6:4, pages 435-444.
Crossref
Crossref
Francesco Del Giudice, Costantino Leonardo, Giuseppe Simone, Martina Pecoraro, Ettore De Berardinis, Stefano Cipollari, Simone Flammia, Marco Bicchetti, Gian Maria Busetto, Benjamin I. Chung, Michele Gallucci, Carlo Catalano & Valeria Panebianco. (2020) Preoperative detection of Vesical Imaging‐Reporting and Data System (VI‐RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?. BJU International 126:5, pages 610-619.
Crossref
Crossref
A. Sud, M.E. Jones, J. Broggio, C. Loveday, B. Torr, A. Garrett, D.L. Nicol, S. Jhanji, S.A. Boyce, F. Gronthoud, P. Ward, J.M. Handy, N. Yousaf, J. Larkin, Y-E. Suh, S. Scott, P.D.P. Pharoah, C. Swanton, C. Abbosh, M. Williams, G. Lyratzopoulos, R. Houlston & C. Turnbull. (2020) Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Annals of Oncology 31:8, pages 1065-1074.
Crossref
Crossref
Amit Sud, Bethany Torr, Michael E Jones, John Broggio, Stephen Scott, Chey Loveday, Alice Garrett, Firza Gronthoud, David L Nicol, Shaman Jhanji, Stephen A Boyce, Matthew Williams, Elio Riboli, David C Muller, Emma Kipps, James Larkin, Neal Navani, Charles Swanton, Georgios Lyratzopoulos, Ethna McFerran, Mark Lawler, Richard Houlston & Clare Turnbull. (2020) Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. The Lancet Oncology 21:8, pages 1035-1044.
Crossref
Crossref
Jeffrey J. Leow, James W.F. Catto, Jason A. Efstathiou, John L. Gore, Ahmed A. Hussein, Shahrokh F. Shariat, Angela B. Smith, Alon Z. Weizer, Manfred Wirth, J. Alfred Witjes & Quoc-Dien Trinh. (2020) Quality Indicators for Bladder Cancer Services: A Collaborative Review. European Urology 78:1, pages 43-59.
Crossref
Crossref
Beth Russell, Fredrik Liedberg, Muhammad Shamim Khan, Rajesh Nair, Ramesh Thurairaja, Sachin Malde, Pardeep Kumar, Richard T. Bryan & Mieke Van Hemelrijck. (2020) A Systematic Review and Meta-analysis of Delay in Radical Cystectomy and the Effect on Survival in Bladder Cancer Patients. European Urology Oncology 3:2, pages 239-249.
Crossref
Crossref
Alice T. Chu, Sarah K. Holt, Jonathan L. Wright, Jorge D. Ramos, Petros Grivas, Evan Y. Yu & John L. Gore. (2019) Delays in radical cystectomy for muscle‐invasive bladder cancer. Cancer 125:12, pages 2011-2017.
Crossref
Crossref
Selma Masic & Marc C. Smaldone. (2019) Treatment delays for muscle‐invasive bladder cancer. Cancer 125:12, pages 1973-1975.
Crossref
Crossref
Daniel Chalk, Neil Trent, Sarath Vennam, John McGrane & Mark Mantle. (2018) Reducing delays in the diagnosis and treatment of muscle-invasive bladder cancer using simulation modelling. Journal of Clinical Urology 12:2, pages 129-133.
Crossref
Crossref
Hakan Türk, Sıtkı Ün, Ahmet Cinkaya, Hilmi Kodaz, Murtaza Parvizi & Ferruh Zorlu. (2018) Effect of delayed radical cystectomy for invasive bladder tumors on lymph node positivity, cancer-specific survival and total survival. Tumori Journal 104:6, pages 434-437.
Crossref
Crossref
Ellen Hollands Steffensen, Clint Cary, Jørgen Bjerggaard Jensen, Heidi Larsson, Michael Weiner & Mette Nørgaard. (2018) Preadmission antidepressant use and bladder cancer: a population-based cohort study of stage at diagnosis, time to surgery, and surgical outcomes. BMC Cancer 18:1.
Crossref
Crossref
Alessandro Antonelli, Stefania Zamboni, Carlotta Palumbo, Sandra Belotti, Marco Lattarulo, Maria Furlan, Maria C. Marconi, Luca Cristinelli & Claudio Simeone. (2018) Prognostic role of delay before radical cystectomy: retrospective analysis of a single-centre cohort with 376 patients. Minerva Urologica e Nefrologica 70:5.
Crossref
Crossref
Peng Ge, Li Wang, Meng Lu, Lijun Mao, Wang Li, Rumin Wen, Jian Lin, Junqi Wang & Jiacun Chen. (2018) Oncological Outcome of Primary and Secondary Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-analysis. Scientific Reports 8:1.
Crossref
Crossref
Brian McGlynn, Maximilian Johnston & James Green. (2017) A nurse-led multidisciplinary team approach in urology-oncology: Addressing the new cancer strategy. Journal of Clinical Urology 10:5, pages 449-456.
Crossref
Crossref
Harman Maxim Bruins, Katja K.H. Aben, Tom J. Arends, Antoine G. van der Heijden & Alfred J. Witjes. (2016) The effect of the time interval between diagnosis of muscle-invasive bladder cancer and radical cystectomy on staging and survival: A Netherlands Cancer Registry analysis. Urologic Oncology: Seminars and Original Investigations 34:4, pages 166.e1-166.e6.
Crossref
Crossref
Jong Chul Park, Nilay M. Gandhi, Michael A. Carducci, Mario A. Eisenberger, Alexander S. Baras, George J. Netto, Jen-Jane Liu, Charles G. Drake, Mark P. Schoenberg, Trinity J. Bivalacqua & Noah M. Hahn. (2016) A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder Cancer. Journal of Urology 195:4 Part 1, pages 880-885.
Crossref
Crossref
Dominic H. Tang & Sam S. Chang. (2015)
Management of carcinoma
in situ
of the bladder: best practice and recent developments
. Therapeutic Advances in Urology 7:6, pages 351-364.
Crossref
Crossref
Tracy L. Rose, Allison M. Deal, Ethan Basch, Paul A. Godley, W. Kimryn Rathmell, William Y. Kim, Young E. Whang, Mary W. Dunn, Andrew Wang, Ronald C. Chen, Matthew E. Nielsen, Raj S. Pruthi, Eric M. Wallen, Michael E. Woods, Angela B. Smith & Matthew I. Milowsky. (2015) Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings. Urologic Oncology: Seminars and Original Investigations 33:9, pages 386.e1-386.e6.
Crossref
Crossref
M Shahid Iqbal, R Pickles, I Pedley, J Frew, A Azzabi, R Heer, A Thorpe, M Johnson, L Robson & R McMenemin. (2014) Delays in the diagnosis and treatment of muscle invasive bladder cancer: A pilot project mapping the pathway. Journal of Clinical Urology 8:4, pages 246-251.
Crossref
Crossref
Fabiano Santos, Alice Dragomir, Wassim Kassouf, Eduardo L. Franco & Armen Aprikian. (2014)
Predictors of preoperative delays before radical cystectomy for bladder cancer in
Q
uebec,
C
anada: a population‐based study
. BJU International 115:3, pages 389-396.
Crossref
Crossref
Atiqullah Aziz, Stephan Madersbacher, Wolfgang Otto, Roman Mayr, Evi Comploj, Armin Pycha, Stefan Denzinger, Hans-Martin Fritsche, Maximilian Burger & Michael Gierth. (2015) Comparative Analysis of Gender-Related Differences in Symptoms and Referral Patterns prior to Initial Diagnosis of Urothelial Carcinoma of the Bladder: A Prospective Cohort Study. Urologia Internationalis 94:1, pages 37-44.
Crossref
Crossref
Matthias May, Maximilian Burger, Sabine Brookman-May, Christian G. Stief, Hans-Martin Fritsche, Jan Roigas, Mario Zacharias, Markus Bader, Philipp Mandel, Christian Gilfrich, Michael Seitz & Derya Tilki. (2014) EORTC Progression Score Identifies Patients at High Risk of Cancer-Specific Mortality After Radical Cystectomy for Secondary Muscle-Invasive Bladder Cancer. Clinical Genitourinary Cancer 12:4, pages 278-286.
Crossref
Crossref
Dong Wook Shin, Juhee Cho, So Young Kim, Eliseo Guallar, Seung Sik Hwang, BeLong Cho, Jae Hwan Oh, Ki Wook Jung, Hong Gwan Seo & Jong Hyock Park. (2013) Delay to Curative Surgery Greater than 12 Weeks Is Associated with Increased Mortality in Patients with Colorectal and Breast Cancer but Not Lung or Thyroid Cancer. Annals of Surgical Oncology 20:8, pages 2468-2476.
Crossref
Crossref
A. Aziz, M. Gierth, H.M. Fritsche, M. May, W. Otto, S. Denzinger, W.F. Wieland, A. Merseburger, H. Riedmiller, A. Kocot & M. Burger. (2013) Oncological Outcome of Primary versus Secondary Muscle-Invasive Bladder Cancer Is Comparable after Radical Cystectomy. Urologia Internationalis 91:1, pages 97-102.
Crossref
Crossref
Matthias May, Christian Stief, Sabine Brookman-May, Wolfgang Otto, Christian Gilfrich, Jan Roigas, Mario Zacharias, Wolf F. Wieland, Hans-Martin Fritsche, Ferdinand Hofstädter & Maximilian Burger. (2011) Gender-dependent cancer-specific survival following radical cystectomy. World Journal of Urology 30:5, pages 707-713.
Crossref
Crossref
Debasish Sundi, Robert S. Svatek, Vitaly Margulis, Christopher G. Wood, Surena F. Matin, Colin P. Dinney & Ashish M. Kamat. (2012) Upper tract urothelial carcinoma: Impact of time to surgery. Urologic Oncology: Seminars and Original Investigations 30:3, pages 266-272.
Crossref
Crossref
Ajjai S. Alva, Christopher T. Tallman, Chang He, Maha H. Hussain, Khaled Hafez, James E. Montie, David C. Smith, Alon Z. Weizer, David Wood & Cheryl T. Lee. (2011) Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle‐invasive bladder cancer. Cancer 118:1, pages 44-53.
Crossref
Crossref
Faysal A. Yafi, Armen G. Aprikian, Joseph L. Chin, Yves Fradet, Jonathan Izawa, Eric Estey, Adrian Fairey, Ricardo Rendon, Ilias Cagiannos, Louis Lacombe, Jean‐Baptiste Lattouf, David Bell, Darrel Drachenberg & Wassim Kassouf. (2010) Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience. BJU International 108:4, pages 539-545.
Crossref
Crossref
Guiyang Cai, Xuefeng Liu & Bin Wu. (2011) Treatment of upper urinary tract urothelial carcinoma. Surgical Oncology 20:1, pages 43-55.
Crossref
Crossref
M. May, H.-M. Fritsche, S. Brookman-May, M. Burger, C. Bolenz, L. Trojan, E. Herrmann, M.S. Michel, C. Wülfing, A. Tiemann, S.C. Müller, J. Ellinger, A. Buchner, C.G. Stief, D. Tilki, W.F. Wieland, C. Gilfrich, T. Höfner, M. Hohenfellner, A. Haferkamp, J. Roigas, M. Zacharias, S. Gunia & P.J. Bastian. (2010) Harnblasenkarzinompatienten im klinischen Tumorstadium T2Patients with bladder cancer in clinical stage T2. Der Urologe 49:12, pages 1508-1515.
Crossref
Crossref
Brent K. Hollenbeck, Rodney L. Dunn, Zaojun Ye, John M. Hollingsworth, Ted A. Skolarus, Simon P. Kim, James E. Montie, Cheryl T. Lee, David P. WoodJr.Jr. & David C. Miller. (2010) Delays in diagnosis and bladder cancer mortality. Cancer 116:22, pages 5235-5242.
Crossref
Crossref
Matthias Waldert, Pierre I. Karakiewicz, Jay D. Raman, Mesut Remzi, Hendrik Isbarn, Yair Lotan, Umberto Capitanio, Karim Bensalah, Michael J. Marberger & Shahrokh F. Shariat. (2010) A delay in radical nephroureterectomy can lead to upstaging. BJU International 105:6, pages 812-817.
Crossref
Crossref
Girish S. Kulkarni, David R. Urbach, Peter C. Austin, Neil E. Fleshner & Andreas Laupacis. (2009) Longer Wait Times Increase Overall Mortality in Patients With Bladder Cancer. Journal of Urology 182:4, pages 1318-1324.
Crossref
Crossref
Udai S. Dwivedi, Abhay Kumar, Suren K. Das, Sameer Trivedi, Mohan Kumar, Shyam Sunder & Pratap B. Singh. (2009) Relook TURBT in superficial bladder cancer: Its importance and its correlation with the tumor ploidy. Urologic Oncology: Seminars and Original Investigations 27:5, pages 514-519.
Crossref
Crossref
Jay B. Shah & Vitaly Margulis. (2009) Nationally representative data in urology. Nature Reviews Urology 6:7, pages 354-355.
Crossref
Crossref
Matthew R. Cooperberg, Michael P. Porter & Badrinath R. Konety. (2009) Candidate quality of care indicators for localized bladder cancer. Urologic Oncology: Seminars and Original Investigations 27:4, pages 435-442.
Crossref
Crossref
John L. Gore, Julie Lai, Claude M. Setodji, Mark S. Litwin & Christopher S. Saigal. (2009) Mortality increases when radical cystectomy is delayed more than 12 weeks. Cancer 115:5, pages 988-996.
Crossref
Crossref
M. Mantle, A. J. Dickinson, M. Moody & R. Cox. (2009) How Quickly are We Treating Muscle Invasive Bladder Cancer? Trends over a 17 Year Period. British Journal of Medical and Surgical Urology 2:1, pages 22-26.
Crossref
Crossref
Matthew R. Cooperberg & Badrinath R. Konety. 2010. Bladder Cancer. Bladder Cancer
177
187
.
Vito Pansadoro & Paolo Emiliozzi. (2008) Bladder-sparing therapy for muscle-infiltrating bladder cancer. Nature Clinical Practice Urology 5:7, pages 368-375.
Crossref
Crossref
Andrew A. Stec, Benjamin J. Coons, Sam S. Chang, Michael S. Cookson, S. Duke Herrell, Joseph A. Smith & Peter E. Clark. (2008) Waiting Time From Initial Urological Consultation to Nephrectomy for Renal Cell Carcinoma—Does it Affect Survival?. Journal of Urology 179:6, pages 2152-2157.
Crossref
Crossref
M. Craig HallSam S. ChangGuido DalbagniRaj Som PruthiJohn Derek SeigneEila Curlee SkinnerJ. Stuart WolfPaul F. Schellhammer. (2007) Guideline for the Management of Nonmuscle Invasive Bladder Cancer (Stages Ta, T1, and Tis): 2007 Update. Journal of Urology 178:6, pages 2314-2330.
Crossref
Crossref
Matthias May, Kay-Patrick Braun, Christian Helke, Willi Richter, Horst Vogler, Bernd Hoschke & Michael Siegsmund. (2007) Lunar phases and zodiac signs do not influence quality of radical cystectomy—a statistical analysis of 452 patients with invasive bladder cancer. International Urology and Nephrology 39:4, pages 1023-1030.
Crossref
Crossref
Matthew E. Nielsen, Ganesh S. Palapattu, Pierre I. Karakiewicz, Yair Lotan, Patrick J. Bastian, Seth P. Lerner, Arthur I. Sagalowsky, Mark P. Schoenberg & Shahrokh F. Shariat. (2007) A delay in radical cystectomy of >3 months is not associated with a worse clinical outcome. BJU International 100:5, pages 1015-1020.
Crossref
Crossref
Christopher S. Saigal. (2007) Quality Indicators for Benign Prostatic Hyperplasia in Vulnerable Elders. Journal of the American Geriatrics Society 55:s2.
Crossref
Crossref
Heather M. Wilson, Ruthanne Chun, Victoria S. Larson, Ilene D. Kurzman & David M. Vail. (2007) Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990–2004). Journal of the American Veterinary Medical Association 231:1, pages 101-106.
Crossref
Crossref
Jacques Irani, Nicolas Mottet, María Jose Ribal Caparrós & Pierre Teillac. (2007) New Trends in Bladder Cancer Management. European Urology Supplements 6:4, pages 388-395.
Crossref
Crossref
Seo Yong ParkHan Yong ChoiHyun Moo Lee. (2007) Predictive Factors of Advancement of the Pathologic T Stage after Radical Cystectomy in Patients with Clinical T2 Stage Bladder Transitional Cell Carcinoma. Korean Journal of Urology 48:4, pages 390.
Crossref
Crossref
Nader M. Fahmy, Salaheddin Mahmud & Armen G. Aprikian. (2006) Delay in the Surgical Treatment of Bladder Cancer and Survival: Systematic Review of the Literature. European Urology 50:6, pages 1176-1182.
Crossref
Crossref
John P. Stein. (2006) Improving outcomes with radical cystectomy for high-grade invasive bladder cancer. World Journal of Urology 24:5, pages 509-516.
Crossref
Crossref
John L. Gore, Christopher S. Saigal, Jan M. Hanley, Matthias Schonlau & Mark S. Litwin. (2006) Variations in reconstruction after radical cystectomy. Cancer 107:4, pages 729-737.
Crossref
Crossref
Cheryl T. Lee, Rabii Madii, Stephanie Daignault, Rodney L. Dunn, Yingxi Zhang, James E. Montie & David P. Wood. (2006) Cystectomy Delay More Than 3 Months From Initial Bladder Cancer Diagnosis Results in Decreased Disease Specific and Overall Survival. Journal of Urology 175:4, pages 1262-1267.
Crossref
Crossref
Adrienne J.K. Carmack & Mark S. Soloway. (2006) The diagnosis and staging of bladder cancer: From RBCs to TURs. Urology 67:3, pages 3-8.
Crossref
Crossref
Alan M. Nieder, Maurizio Brausi, Donald Lamm, Michael O’Donnell, Kyouichi Tomita, Henry Woo & Michael A.S. Jewett. (2005) Management of stage T1 tumors of the bladder: International Consensus Panel. Urology 66:6, pages 108-125.
Crossref
Crossref
FREDRIK LIEDBERG, HARALD ANDERSON & WIKING MÅNSSON. (2005) TREATMENT DELAY AND PROGNOSIS IN INVASIVE BLADDER CANCER. Journal of Urology 174:5, pages 1777-1781.
Crossref
Crossref
Murugesan Manoharan & Mark S. Soloway. (2005) Optimal Management of the T1G3 Bladder Cancer. Urologic Clinics of North America 32:2, pages 133-145.
Crossref
Crossref